# FDA Inspection 1293216 - Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd - October 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/c8a11391-9a4e-4d9a-bd14-ca7e591b5b9a
Source feed: FDA_Inspections

> FDA Inspection 1293216 for Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd on October 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293216
- Company Name: Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd
- Inspection Date: 2025-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293216 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/862a3d02-d615-4745-a20f-e4c00e04057c)
- [FDA Inspection 1293216 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/eb40ccae-71b1-45da-a8f9-251bc5918e4f)
- [FDA Inspection 1293216 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/8001e4f1-c19c-4f14-9133-ba9425a61ab7)
- [FDA Inspection 1209415 - 2023-06-02](https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/4ee38c51-ce3c-4495-b568-0947693db01c)
- [FDA Inspection 1209415 - 2023-06-02](https://www.keypedia.com/records/fda_inspections/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/08c80009-eaac-45e6-ad63-1dabcf3a519f)

Company: https://www.keypedia.com/companies/zhejiang-apeloa-tospo-pharmaceuticals-co-ltd/0a04fd37-1d04-4aa6-96f6-a25e6b2c756b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c